/OPCH
OPCH Stock - Option Care Health, Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$35.05+9.33%
+$2.99 (+9.33%) • Jan 13
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.86
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).65
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.88
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+7.3%upside
Target: $37.61
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OPCH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$34.70 – $35.40
TARGET (TP)$37.60
STOP LOSS$32.25
RISK/REWARD1:0.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.81
52W High$35.53
52W Low$24.24
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.00B | $4.30B | $3.94B | $3.44B | $3.03B |
| Gross Profit | $1.01B | $981.22M | $866.92M | $779.61M | $682.26M |
| Gross Margin | 20.3% | 22.8% | 22.0% | 22.7% | 22.5% |
| Operating Income | $321.83M | $314.60M | $240.23M | $190.84M | $110.75M |
| Net Income | $211.82M | $267.09M | $150.56M | $139.90M | $-8,076,000 |
| Net Margin | 4.2% | 6.2% | 3.8% | 4.1% | -0.3% |
| EPS | $1.23 | $1.49 | $0.83 | $0.78 | $-0.04 |
Company Overview
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
5
50%
Hold / Neutral
5
50%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
5 Bullish5 Neutral/Bearish
Price Targets
$33
Average Target
↓ 6.6% Downside
Now
$26
Low
$33
Average
$40
High
Based on 11 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 11th 2025 | Stephens | Initiation | Overweight | $40 |
| October 2nd 2025 | TD Cowen | Initiation | Hold | $30 |
| April 30th 2025 | UBS | Upgrade | Buy | $40 |
| January 23rd 2025 | Jefferies | Upgrade | Buy | $35← $26 |
| January 13th 2025 | BofA Securities | Upgrade | Buy | $33← $26 |
| December 5th 2024 | UBS | Initiation | Neutral | $26 |
| November 4th 2024 | Goldman | Downgrade | Neutral | $27 |
| October 31st 2024 | Jefferies | Downgrade | Hold | $26← $38 |
| October 30th 2024 | BofA Securities | Downgrade | Neutral | $29← $43 |
| July 16th 2024 | JMP Securities | Initiation | Mkt Outperform | $36 |
| February 27th 2023 | Jefferies | Resumed | Buy | $38 |
Earnings History & Surprises
OPCHBeat Rate
68%
Last 19 quarters
Avg Surprise
+10.3%
EPS vs Estimate
Beats / Misses
13/2
4 met exactly
Latest EPS
$0.45
Q4 2025
EPS Surprise History
Q1 24
+10.3%
$0.32vs$0.29
Q2 24
+13.0%
$0.26vs$0.23
Q3 24
+11.1%
$0.30vs$0.27
Q4 24
0.0%
$0.31vs$0.31
Q1 25
+6.1%
$0.35vs$0.33
Q2 25
+11.1%
$0.40vs$0.36
Q3 25
+2.5%
$0.41vs$0.40
Q4 25
+4.7%
$0.45vs$0.43
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | $0.46 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.43 | $0.45 | +4.7% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.40 | $0.41 | +2.5% | ✓ BEAT |
Q2 2025 | Apr 29, 2025 | $0.36 | $0.40 | +11.1% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $0.33 | $0.35 | +6.1% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.31 | $0.31 | 0.0% | = MET |
Q3 2024 | Jul 31, 2024 | $0.27 | $0.30 | +11.1% | ✓ BEAT |
Q2 2024 | Apr 23, 2024 | $0.23 | $0.26 | +13.0% | ✓ BEAT |
Q1 2024 | Feb 22, 2024 | $0.29 | $0.32 | +10.3% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $0.28 | $0.31 | +10.7% | ✓ BEAT |
Q3 2023 | Jul 27, 2023 | $0.22 | $0.63 | +186.4% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.18 | $0.21 | +16.7% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $0.22 | $0.22 | 0.0% | = MET |
Q4 2022 | Oct 27, 2022 | $0.21 | $0.21 | 0.0% | = MET |
Q3 2022 | Jul 27, 2022 | $0.22 | $0.19 | -13.6% | ✗ MISS |
Q2 2022 | Apr 28, 2022 | $0.13 | $0.17 | +30.8% | ✓ BEAT |
Q1 2022 | Feb 23, 2022 | $0.24 | $0.24 | 0.0% | = MET |
Q4 2021 | Nov 4, 2021 | $0.19 | $0.20 | +5.3% | ✓ BEAT |
Q3 2021 | Aug 3, 2021 | $0.09 | $0.18 | +100.0% | ✓ BEAT |
Q2 2021 | May 6, 2021 | $-0.01 | $-0.02 | -199.9% | ✗ MISS |
Latest News
Morgan Stanley Maintains Overweight on Option Care Health, Raises Price Target to $38
📈 PositiveBenzinga•Jan 13, 2026, 04:30 PM
Option Care Health shares are trading higher after the company reported preliminary Q4 and FY25 financial results. a
📈 PositiveBenzinga•Jan 13, 2026, 04:18 PM
Citizens Reiterates Market Outperform on Option Care Health, Raises Price Target to $38
📈 PositiveBenzinga•Jan 13, 2026, 02:40 PM
Option Care Health Approves Increase To Its 2025 Share Repurchase Program Authorization, From $500M To $1B
📈 PositiveBenzinga•Jan 12, 2026, 09:39 PM
Option Care Health Reports Q4 Preliminary Adjusted EPS Of $0.46 - $0.49, Net Revenue Of $1.46B - $1.47B; FY25 Adjusted EPS Of $1.72 - $1.76, Net Revenue Of $5.645B - $5.655B; Expects FY26 Adjusted EPS Range $1.82 To $1.92, Net Revenue Range $5.8B To $6B
📈 PositiveBenzinga•Jan 12, 2026, 09:38 PM
Stephens & Co. Initiates Coverage On Option Care Health with Overweight Rating, Announces Price Target of $40
📈 PositiveBenzinga•Dec 11, 2025, 09:37 AM
B of A Securities Maintains Buy on Option Care Health, Raises Price Target to $35
📈 PositiveBenzinga•Dec 9, 2025, 05:50 PM
Deutsche Bank Maintains Buy on Option Care Health, Raises Price Target to $36
📈 PositiveBenzinga•Dec 9, 2025, 05:03 PM•Also:
TD Cowen Maintains Hold on Option Care Health, Lowers Price Target to $27
📉 NegativeBenzinga•Nov 3, 2025, 04:26 PM
Citizens Maintains Market Outperform on Option Care Health, Lowers Price Target to $36
➖ NeutralBenzinga•Oct 31, 2025, 12:01 PM
Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
📈 PositiveBenzinga•Oct 31, 2025, 11:53 AM
Option Care Health shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Oct 30, 2025, 12:56 PM
Option Care Health Raises FY2025 Adj EPS Guidance from $1.65-$1.72 to $1.68-$1.72 vs $1.71 Est; Raises FY2025 Sales Guidance from $5.500B-$5.650B to $5.600B-$5.650B vs $5.626B Est
📈 PositiveBenzinga•Oct 30, 2025, 11:01 AM
Option Care Health Q3 2025 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $1.435B Beat $1.413B Estimate
📈 PositiveBenzinga•Oct 30, 2025, 11:00 AM
Morgan Stanley Initiates Coverage On Option Care Health with Overweight Rating, Announces Price Target of $35
📈 PositiveBenzinga•Oct 17, 2025, 11:55 AM
TD Cowen Initiates Coverage On Option Care Health with Hold Rating, Announces Price Target of $30
➖ NeutralBenzinga•Oct 2, 2025, 02:09 PM
Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
📈 PositiveBenzinga•Sep 23, 2025, 03:21 PM
Option Care Health Appoints Meenal Sethna As Executive Vice President And CFO, Effective October 1, 2025; Succeeds Mike Shapiro
➖ NeutralBenzinga•Aug 20, 2025, 12:47 PM
Frequently Asked Questions about OPCH
What is OPCH's current stock price?
Option Care Health, Inc. (OPCH) is currently trading at $35.05 per share. The stock has moved +9.33% today.
What is the analyst price target for OPCH?
The average analyst price target for OPCH is $37.60, based on 1 analyst.
What sector is Option Care Health, Inc. in?
Option Care Health, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is OPCH's market cap?
Option Care Health, Inc. has a market capitalization of $5.77 billion, making it a mid-cap company.
Does OPCH pay dividends?
No, Option Care Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACAD
ACADIA Pharmaceuticals Inc.
$26.50
Mkt Cap: $4.5B
ADMA
ADMA Biologics, Inc.
$17.58
Mkt Cap: $4.2B
AKRO
Akero Therapeutics, Inc.
$54.65
Mkt Cap: $4.5B
HNGE
Hinge Health, Inc.
$46.40
Mkt Cap: $3.7B
IMVT
Immunovant, Inc.
$26.32
Mkt Cap: $4.6B
INDV
Indivior PLC
$33.85
Mkt Cap: $4.2B
KYMR
Kymera Therapeutics, Inc.
$73.92
Mkt Cap: $5.3B
LNTH
Lantheus Holdings, Inc.
$64.84
Mkt Cap: $4.4B
OSCR
Oscar Health, Inc.
$17.32
Mkt Cap: $4.4B
TMDX
TransMedics Group, Inc.
$144.17
Mkt Cap: $4.9B
Explore stocks similar to OPCH for comparison